{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:44:14Z","timestamp":1790858654170,"version":"4.1.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s12015-023-10653-8","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T16:02:33Z","timestamp":1699891353000},"page":"138-158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cell Therapy Strategies on Duchenne Muscular Dystrophy: A Systematic Review of Clinical Applications"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6592-8369","authenticated-orcid":false,"given":"Ayberk","family":"Akat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9992-833X","authenticated-orcid":false,"given":"Erdal","family":"Kara\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"issue":"9869","key":"10653_CR1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/s0140-6736(12)61897-2","volume":"381","author":"E Mercuri","year":"2013","unstructured":"Mercuri, E., & Muntoni, F. (2013). Muscular dystrophies. The Lancet, 381(9869), 845\u2013860. https:\/\/doi.org\/10.1016\/s0140-6736(12)61897-2","journal-title":"The Lancet"},{"issue":"9307","key":"10653_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/s0140-6736(02)07815-7","volume":"359","author":"AE Emery","year":"2002","unstructured":"Emery, A. E. (2002). The muscular dystrophies. The Lancet, 359(9307), 687\u2013695. https:\/\/doi.org\/10.1016\/s0140-6736(02)07815-7","journal-title":"The Lancet"},{"issue":"6","key":"10653_CR3","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ahj.2008.01.018","volume":"155","author":"DM Connuck","year":"2008","unstructured":"Connuck, D. M., Sleeper, L. A., Colan, S. D., Cox, G. F., Towbin, J. A., Lowe, A. M., Wilkinson, J. D., Orav, E. J., Cuniberti, L., Salbert, B. A., Lipshultz, S. E., Pediatric Cardiomyopathy Registry Study Group. (2008). Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. American Heart Journal, 155(6), 998\u20131005. https:\/\/doi.org\/10.1016\/j.ahj.2008.01.018","journal-title":"American heart journal"},{"key":"10653_CR4","doi-asserted-by":"publisher","first-page":"FV16_04","DOI":"10.1055\/s-0033-1337748","volume":"44","author":"M Freilinger","year":"2013","unstructured":"Freilinger, M., Schmidt, I., Dysek, S., Seidl, R., Schmidt, W. M., & Bittner, R. E. (2013). Muscle-specific discordant skewing of X chromosome inactivation leads to different clinical phenotypes of Duchenne muscular dystrophy in two monozygotic female twins. Neuropediatrics, 44, FV16_04.","journal-title":"Neuropediatrics"},{"issue":"1","key":"10653_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/jmg.2.1.38","volume":"2","author":"P Ferrier","year":"1965","unstructured":"Ferrier, P., Bamatter, F., & Klein, D. (1965). Muscular dystrophy (Duchenne) in a girl with Turner\u2019s syndrome. Journal of Medical Genetics, 2(1), 38\u201346. https:\/\/doi.org\/10.1136\/jmg.2.1.38","journal-title":"Journal of Medical Genetics"},{"issue":"2","key":"10653_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF00282093","volume":"74","author":"J Chelly","year":"1986","unstructured":"Chelly, J., Marlhens, F., Le Marec, B., Jeanpierre, M., Lambert, M., Hamard, G., Dutrillaux, B., & Kaplan, J. C. (1986). De novo DNA microdeletion in a girl with Turner syndrome and Duchenne muscular dystrophy. Human Genetics, 74(2), 193\u2013196. https:\/\/doi.org\/10.1007\/BF00282093","journal-title":"Human Genetics"},{"issue":"11","key":"10653_CR7","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/pd.1031","volume":"24","author":"V Satre","year":"2004","unstructured":"Satre, V., Monnier, N., Devillard, F., Amblard, F., & Lunardi, J. (2004). Prenatal diagnosis of DMD in a female fetus affected by Turner syndrome. Prenatal Diagnosis, 24(11), 913\u2013917. https:\/\/doi.org\/10.1002\/pd.1031","journal-title":"Prenatal Diagnosis"},{"issue":"3","key":"10653_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant, D. J., Bushby, K., Bann, C. M., Apkon, S. D., Blackwell, A., Brumbaugh, D., Case, L. E., Clemens, P. R., Hadjiyannakis, S., Pandya, S., Street, N., Tomezsko, J., Wagner, K. R., Ward, L. M., Weber, D. R., DMD Care Considerations Working Group. (2018). Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. The Lancet. Neurology, 17(3), 251\u2013267. https:\/\/doi.org\/10.1016\/S1474-4422(18)30024-3","journal-title":"The Lancet. Neurology"},{"key":"10653_CR9","doi-asserted-by":"publisher","first-page":"175675","DOI":"10.1016\/j.ejphar.2023.175675","volume":"947","author":"G Patterson","year":"2023","unstructured":"Patterson, G., Conner, H., Groneman, M., Blavo, C., & Parmar, M. S. (2023). Duchenne muscular dystrophy: Current treatment and emerging exon skipping and gene therapy approach. European Journal of Pharmacology, 947, 175675. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175675","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10653_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2006.09.016","volume":"36","author":"N Deconinck","year":"2007","unstructured":"Deconinck, N., & Dan, B. (2007). Pathophysiology of Duchenne muscular dystrophy: Current hypotheses. Pediatric Neurology, 36(1), 1\u20137. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2006.09.016","journal-title":"Pediatric Neurology"},{"issue":"1","key":"10653_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan, D., Goemans, N., Takeda, S., Mercuri, E., & Aartsma-Rus, A. (2021). Duchenne muscular dystrophy. Nature Reviews Disease Primers, 7(1), 13. https:\/\/doi.org\/10.1038\/s41572-021-00248-3","journal-title":"Nature Reviews Disease Primers"},{"issue":"17","key":"10653_CR12","doi-asserted-by":"publisher","first-page":"e1597","DOI":"10.1212\/WNL.0000000000008363","volume":"93","author":"M Thangarajh","year":"2019","unstructured":"Thangarajh, M., Hendriksen, J., McDermott, M. P., Martens, W., Hart, K. A., Griggs, R. C., Muscle Study Group and TREAT-NMD. (2019). Relationships between DMD mutations and neurodevelopment in dystrophinopathy. Neurology, 93(17), e1597\u2013e1604. https:\/\/doi.org\/10.1212\/WNL.0000000000008363","journal-title":"Neurology"},{"issue":"10","key":"10653_CR13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","volume":"21","author":"SJ Moat","year":"2013","unstructured":"Moat, S. J., Bradley, D. M., Salmon, R., Clarke, A., & Hartley, L. (2013). Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK). European Journal of Human Genetics, 21(10), 1049\u20131053. https:\/\/doi.org\/10.1038\/ejhg.2012.301","journal-title":"European Journal of Human Genetics"},{"issue":"9","key":"10653_CR14","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","volume":"77","author":"JR Mendell","year":"2020","unstructured":"Mendell, J. R., Sahenk, Z., Lehman, K., Nease, C., Lowes, L. P., Miller, N. F., Iammarino, M. A., Alfano, L. N., Nicholl, A., Al-Zaidy, S., Lewis, S., Church, K., Shell, R., Cripe, L. H., Potter, R. A., Griffin, D. A., Pozsgai, E., Dugar, A., Hogan, M., & Rodino-Klapac, L. R. (2020). Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial. JAMA Neurology, 77(9), 1122\u20131131. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1484","journal-title":"JAMA Neurology"},{"issue":"3","key":"10653_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nm.1916","volume":"15","author":"AM Bellinger","year":"2009","unstructured":"Bellinger, A. M., Reiken, S., Carlson, C., Mongillo, M., Liu, X., Rothman, L., Matecki, S., Lacampagne, A., & Marks, A. R. (2009). Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nature Medicine, 15(3), 325\u2013330. https:\/\/doi.org\/10.1038\/nm.1916","journal-title":"Nature Medicine"},{"issue":"2","key":"10653_CR16","first-page":"121","volume":"31","author":"L Passamano","year":"2012","unstructured":"Passamano, L., Taglia, A., Palladino, A., Viggiano, E., D\u2019Ambrosio, P., Scutifero, M., Rosaria Cecio, M., Torre, V., De Luca, F., Picillo, E., Paciello, O., Piluso, G., Nigro, G., & Politano, L. (2012). Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients. Acta Myologica\u202f: Myopathies and Cardiomyopathies: Official Journal of the Mediterranean Society of Myology, 31(2), 121\u2013125.","journal-title":"Acta myologica : myopathies and cardiomyopathies: Official Journal of the Mediterranean Society of Myology"},{"issue":"5","key":"10653_CR17","doi-asserted-by":"publisher","first-page":"00176","DOI":"10.1183\/23120541.00176-2023","volume":"9","author":"A Lechner","year":"2023","unstructured":"Lechner, A., Herzig, J. J., Kientsch, J. G., Kohler, M., Bloch, K. E., Ulrich, S., & Schwarz, E. I. (2023). Cardiomyopathy as cause of death in Duchenne muscular dystrophy: A longitudinal observational study. ERJ Open Research, 9(5), 00176\u201302023. https:\/\/doi.org\/10.1183\/23120541.00176-2023","journal-title":"ERJ Open Research"},{"issue":"3","key":"10653_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.23528","volume":"71","author":"JR Mendell","year":"2012","unstructured":"Mendell, J. R., Shilling, C., Leslie, N. D., Flanigan, K. M., al-Dahhak, R., Gastier-Foster, J., Kneile, K., Dunn, D. M., Duval, B., Aoyagi, A., Hamil, C., Mahmoud, M., Roush, K., Bird, L., Rankin, C., Lilly, H., Street, N., Chandrasekar, R., & Weiss, R. B. (2012). Evidence-based path to newborn screening for Duchenne muscular dystrophy. Annals of Neurology, 71(3), 304\u2013313. https:\/\/doi.org\/10.1002\/ana.23528","journal-title":"Annals of Neurology"},{"issue":"3","key":"10653_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1542\/peds.2014-2044","volume":"135","author":"PA Romitti","year":"2015","unstructured":"Romitti, P. A., Zhu, Y., Puzhankara, S., James, K. A., Nabukera, S. K., Zamba, G. K., Ciafaloni, E., Cunniff, C., Druschel, C. M., Mathews, K. D., Matthews, D. J., Meaney, F. J., Andrews, J. G., Conway, K. M., Fox, D. J., Street, N., Adams, M. M., Bolen, J., MD STARnet. (2015). Prevalence of Duchenne and Becker muscular dystrophies in the United States. Pediatrics, 135(3), 513\u2013521. https:\/\/doi.org\/10.1542\/peds.2014-2044","journal-title":"Pediatrics"},{"key":"10653_CR20","doi-asserted-by":"publisher","first-page":"950651","DOI":"10.3389\/fphar.2022.950651","volume":"13","author":"J Deng","year":"2022","unstructured":"Deng, J., Zhang, J., Shi, K., & Liu, Z. (2022). Drug development progress in Duchenne muscular dystrophy. Frontiers in Pharmacology, 13, 950651. https:\/\/doi.org\/10.3389\/fphar.2022.950651","journal-title":"Frontiers in Pharmacology"},{"key":"10653_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/DDDT.S97635","volume":"11","author":"KR Lim","year":"2017","unstructured":"Lim, K. R., Maruyama, R., & Yokota, T. (2017). Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug Design, Development and Therapy, 11, 533\u2013545. https:\/\/doi.org\/10.2147\/DDDT.S97635","journal-title":"Drug Design, Development and Therapy"},{"issue":"4","key":"10653_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/jhg.2016.152","volume":"62","author":"A Nakamura","year":"2017","unstructured":"Nakamura, A., Shiba, N., Miyazaki, D., Nishizawa, H., Inaba, Y., Fueki, N., Maruyama, R., Echigoya, Y., & Yokota, T. (2017). Comparison of the phenotypes of patients harboring in-frame deletions starting at exon 45 in the Duchenne muscular dystrophy gene indicates potential for the development of exon skipping therapy. Journal of Human Genetics, 62(4), 459\u2013463. https:\/\/doi.org\/10.1038\/jhg.2016.152","journal-title":"Journal of Human Genetics"},{"key":"10653_CR23","doi-asserted-by":"publisher","first-page":"113086","DOI":"10.1016\/j.expneurol.2019.113086","volume":"323","author":"C Sun","year":"2020","unstructured":"Sun, C., Serra, C., Lee, G., & Wagner, K. R. (2020). Stem cell-based therapies for Duchenne muscular dystrophy. Experimental Neurology, 323, 113086. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113086","journal-title":"Experimental Neurology"},{"issue":"2","key":"10653_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1442-200x.1991.tb01545.x","volume":"33","author":"PK Law","year":"1991","unstructured":"Law, P. K., Goodwin, T. G., Fang, Q. W., Chen, M., Li, H. J., Florendo, J. A., & Kirby, D. S. (1991). Myoblast transfer therapy for Duchenne muscular dystrophy. Acta Paediatrica Japonica, 33(2), 206\u2013215. https:\/\/doi.org\/10.1111\/j.1442-200x.1991.tb01545.x","journal-title":"Acta Paediatrica Japonica"},{"issue":"2\u20133","key":"10653_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/0963689792001002-305","volume":"1","author":"PK Law","year":"1992","unstructured":"Law, P. K., Goodwin, T. G., Fang, Q., Duggirala, V., Larkin, C., Florendo, J. A., Kirby, D. S., Deering, M. B., Li, H. J., & Chen, M. (1992). Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys. Cell Transplantation, 1(2\u20133), 235\u2013244. https:\/\/doi.org\/10.1177\/0963689792001002-305","journal-title":"Cell Transplantation"},{"issue":"5","key":"10653_CR26","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/mus.880150504","volume":"15","author":"J Huard","year":"1992","unstructured":"Huard, J., Bouchard, J. P., Roy, R., Malouin, F., Dansereau, G., Labrecque, C., Albert, N., Richards, C. L., Lemieux, B., & Tremblay, J. P. (1992). Human myoblast transplantation: Preliminary results of 4 cases. Muscle & Nerve, 15(5), 550\u2013560. https:\/\/doi.org\/10.1002\/mus.880150504","journal-title":"Muscle & Nerve"},{"issue":"6368","key":"10653_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/356435a0","volume":"356","author":"E Gussoni","year":"1992","unstructured":"Gussoni, E., Pavlath, G. K., Lanctot, A. M., Sharma, K. R., Miller, R. G., Steinman, L., & Blau, H. M. (1992). Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature, 356(6368), 435\u2013438. https:\/\/doi.org\/10.1038\/356435a0","journal-title":"Nature"},{"issue":"5\u20136","key":"10653_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/0960-8966(93)90121-y","volume":"3","author":"JP Tremblay","year":"1993","unstructured":"Tremblay, J. P., Bouchard, J. P., Malouin, F., Th\u00e9au, D., Cottrell, F., Collin, H., Rouche, A., Gilgenkrantz, S., Abbadi, N., & Tremblay, M. (1993). Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy. Neuromuscular Disorders: NMD, 3(5\u20136), 583\u2013592. https:\/\/doi.org\/10.1016\/0960-8966(93)90121-y","journal-title":"Neuromuscular Disorders: NMD"},{"issue":"7","key":"10653_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.nmd.2013.04.007","volume":"23","author":"JY Hogrel","year":"2013","unstructured":"Hogrel, J. Y., Zagnoli, F., Canal, A., Fraysse, B., Bouchard, J. P., Skuk, D., Fardeau, M., & Tremblay, J. P. (2013). Assessment of a symptomatic Duchenne muscular dystrophy carrier 20 years after myoblast transplantation from her asymptomatic identical twin sister. Neuromuscular Disorders: NMD, 23(7), 575\u2013579. https:\/\/doi.org\/10.1016\/j.nmd.2013.04.007","journal-title":"Neuromuscular Disorders: NMD"},{"issue":"1","key":"10653_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ana.410340105","volume":"34","author":"G Karpati","year":"1993","unstructured":"Karpati, G., Ajdukovic, D., Arnold, D., Gledhill, R. B., Guttmann, R., Holland, P., Koch, P. A., Shoubridge, E., Spence, D., & Vanasse, M. (1993). Myoblast transfer in Duchenne muscular dystrophy. Annals of Neurology, 34(1), 8\u201317. https:\/\/doi.org\/10.1002\/ana.410340105","journal-title":"Annals of Neurology"},{"issue":"13","key":"10653_CR31","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1056\/NEJM199509283331303","volume":"333","author":"JR Mendell","year":"1995","unstructured":"Mendell, J. R., Kissel, J. T., Amato, A. A., King, W., Signore, L., Prior, T. W., Sahenk, Z., Benson, S., McAndrew, P. E., & Rice, R. (1995). Myoblast transfer in the treatment of Duchenne\u2019s muscular dystrophy. The New England Journal of Medicine, 333(13), 832\u2013838. https:\/\/doi.org\/10.1056\/NEJM199509283331303","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10653_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/(sici)1097-4598(199704)20:4<469::aid-mus10>3.0.co;2-u","volume":"20","author":"RG Miller","year":"1997","unstructured":"Miller, R. G., Sharma, K. R., Pavlath, G. K., Gussoni, E., Mynhier, M., Lanctot, A. M., Greco, C. M., Steinman, L., & Blau, H. M. (1997). Myoblast implantation in Duchenne muscular dystrophy: The San Francisco study. Muscle & Nerve, 20(4), 469\u2013478. https:\/\/doi.org\/10.1002\/(sici)1097-4598(199704)20:4%3c469::aid-mus10%3e3.0.co;2-u","journal-title":"Muscle & Nerve"},{"issue":"1","key":"10653_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.nmd.2006.10.003","volume":"17","author":"D Skuk","year":"2007","unstructured":"Skuk, D., Goulet, M., Roy, B., Piette, V., C\u00f4t\u00e9, C. H., Chapdelaine, P., Hogrel, J., Paradis, M., Bouchard, J. P., Sylvain, M., Lachance, G., & Tremblay, J. P. (2007). First test of a \u201chigh-density injection\u201d protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: Eighteen months follow-up. Neuromuscular Disorders, 17(1), 38\u201346. https:\/\/doi.org\/10.1016\/j.nmd.2006.10.003","journal-title":"Neuromuscular Disorders"},{"issue":"6","key":"10653_CR34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3727\/000000007783465064","volume":"16","author":"Y Torrente","year":"2007","unstructured":"Torrente, Y., Belicchi, M., Marchesi, C., D\u2019Antona, G., Cogiamanian, F., Pisati, F., Gavina, M., Giordano, R., Tonlorenzi, R., Fagiolari, G., Lamperti, C., Porretti, L., Lopa, R., Sampaolesi, M., Vicentini, L., Grimoldi, N., Tiberio, F., Songa, V., Baratta, P., \u2026 Bresolin, N. (2007). Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplantation, 16(6), 563\u2013577. https:\/\/doi.org\/10.3727\/000000007783465064","journal-title":"Cell Transplantation"},{"issue":"Suppl 1","key":"10653_CR35","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.3727\/096368913X672136","volume":"22","author":"A Sharma","year":"2013","unstructured":"Sharma, A., Sane, H., Badhe, P., Gokulchandran, N., Kulkarni, P., Lohiya, M., Biju, H., & Jacob, V. C. (2013). A clinical study shows safety and efficacy of autologous bone marrow mononuclear cell therapy to improve quality of life in muscular dystrophy patients. Cell Transplantation, 22(Suppl 1), S127\u2013S138. https:\/\/doi.org\/10.3727\/096368913X672136","journal-title":"Cell Transplantation"},{"key":"10653_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.12659\/AJCR.890078","volume":"15","author":"A Sharma","year":"2014","unstructured":"Sharma, A., Sane, H., Paranjape, A., Bhagawanani, K., Gokulchandran, N., & Badhe, P. (2014). Autologous bone marrow mononuclear cell transplantation in Duchenne muscular dystrophy - a case report. The American Journal of Case Reports, 15, 128\u2013134. https:\/\/doi.org\/10.12659\/AJCR.890078","journal-title":"The American Journal of Case Reports"},{"key":"10653_CR37","doi-asserted-by":"publisher","unstructured":"Cossu, G., Previtali, S. C., Napolitano, S., Cicalese, M. P., Tedesco, F. S., Nicastro, F., Noviello, M., Roostalu, U., Natali Sora, M. G., Scarlato, M., De Pellegrin, M., Godi, C., Giuliani, S., Ciotti, F., Tonlorenzi, R., Lorenzetti, I., Rivellini, C., Benedetti, S., Gatti, R., Marktel, S., \u2026 Ciceri, F. (2015). Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy. EMBO Molecular Medicine, 7(12), 1513\u20131528. https:\/\/doi.org\/10.15252\/emmm.201505636","DOI":"10.15252\/emmm.201505636"},{"issue":"2","key":"10653_CR38","first-page":"141","volume":"10","author":"BS Rajput","year":"2015","unstructured":"Rajput, B. S., Chakrabarti, S. K., Dongare, V. S., Ramirez, C. M., & Deb, K. D. (2015). Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Duchenne Muscular Dystrophy: Safety and Feasibility Study in India. Journal of Stem Cells, 10(2), 141\u2013156.","journal-title":"Journal of Stem Cells"},{"key":"10653_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/DNND.S170087","volume":"8","author":"A Dai","year":"2018","unstructured":"Dai, A., Baspinar, O., Ye\u015filyurt, A., Sun, E., Aydemir, \u00c7. \u0130, \u00d6ztel, O. N., Capkan, D. U., Pinarli, F., Agar, A., & Kara\u00f6z, E. (2018). Efficacy of stem cell therapy in ambulatory and nonambulatory children with Duchenne muscular dystrophy - Phase I-II. Degenerative Neurological and Neuromuscular Disease, 8, 63\u201377. https:\/\/doi.org\/10.2147\/DNND.S170087","journal-title":"Degenerative Neurological and Neuromuscular Disease"},{"key":"10653_CR40","doi-asserted-by":"publisher","unstructured":"Rajput, B., Meher, K., Somalapur, P., Kulkarni, R., Bopardikar, A., & Kumar, R. (2019). Safety and Efficacy of a Combination Therapy (Autologous Bone Marrow-Derived Mononuclear Cells and Umbilical Cord-Derived Mesenchymal Stem Cells) in Duchenne Muscular Dystrophy Patients. Journal of Embryology & Stem Cell Research, 3(2). https:\/\/doi.org\/10.23880\/jes-16000127.","DOI":"10.23880\/jes-16000127"},{"issue":"10","key":"10653_CR41","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1002\/sctm.21-0027","volume":"10","author":"B \u015awi\u0105tkowska-Flis","year":"2021","unstructured":"\u015awi\u0105tkowska-Flis, B., Zdoli\u0144ska-Malinowska, I., S\u0142ugocka, D., & Boruczkowski, D. (2021). The use of umbilical cord-derived mesenchymal stem cells in patients with muscular dystrophies: Results from compassionate use in real-life settings. Stem Cells Translational Medicine, 10(10), 1372\u20131383. https:\/\/doi.org\/10.1002\/sctm.21-0027","journal-title":"Stem Cells Translational Medicine"},{"issue":"8","key":"10653_CR42","doi-asserted-by":"publisher","first-page":"e866","DOI":"10.1212\/WNL.0000000000006950","volume":"92","author":"M Taylor","year":"2019","unstructured":"Taylor, M., Jefferies, J., Byrne, B., Lima, J., Ambale-Venkatesh, B., Ostovaneh, M. R., Makkar, R., Goldstein, B., Smith, R. R., Fudge, J., Malliaras, K., Fedor, B., Rudy, J., Pogoda, J. M., Marb\u00e1n, L., Ascheim, D. D., Marb\u00e1n, E., & Victor, R. G. (2019). Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial. Neurology, 92(8), e866\u2013e878. https:\/\/doi.org\/10.1212\/WNL.0000000000006950","journal-title":"Neurology"},{"key":"10653_CR43","doi-asserted-by":"publisher","unstructured":"McDonald, C. M., Marb\u00e1n, E., Hendrix, S., Hogan, N., Ruckdeschel Smith, R., Eagle, M., Finkel, R. S., Tian, C., Janas, J., Harmelink, M. M., Varadhachary, A. S., Taylor, M. D., Hor, K. N., Mayer, O. H., Henricson, E. K., Furlong, P., Ascheim, D. D., Rogy, S., Williams, P., Marb\u00e1n, L., \u2026 HOPE-2 Study Group (2022). Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet (London, England), 399(10329), 1049\u20131058. https:\/\/doi.org\/10.1016\/S0140-6736(22)00012-5","DOI":"10.1016\/S0140-6736(22)00012-5"},{"issue":"5","key":"10653_CR44","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1007\/s12015-023-10530-4","volume":"19","author":"A Heydemann","year":"2023","unstructured":"Heydemann, A., Bieganski, G., Wachowiak, J., Czarnota, J., Niezgoda, A., Siemionow, K., Ziemiecka, A., Sikorska, M. H., Bozyk, K., Tullius, S. G., & Siemionow, M. (2023). Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First-in-Human Study with Minimum 6 Months Follow-up. Stem Cell Reviews and Reports, 19(5), 1340\u20131359. https:\/\/doi.org\/10.1007\/s12015-023-10530-4","journal-title":"Stem Cell Reviews and Reports"},{"key":"10653_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-023-10620-3.Advanceonlinepublication.10.1007\/s12015-023-10620-3","author":"M Siemionow","year":"2023","unstructured":"Siemionow, M., Biega\u0144ski, G., Niezgoda, A., Wachowiak, J., Czarnota, J., Siemionow, K., Ziemiecka, A., Sikorska, M. H., Bo\u017cyk, K., & Heydemann, A. (2023). Safety and Efficacy of DT-DEC01 Therapy in Duchenne Muscular Dystrophy Patients: A 12 - Month Follow-Up Study After Systemic Intraosseous Administration. Stem Cell Reviews and Reports. https:\/\/doi.org\/10.1007\/s12015-023-10620-3.Advanceonlinepublication.10.1007\/s12015-023-10620-3","journal-title":"Stem Cell Reviews and Reports"},{"issue":"10","key":"10653_CR46","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/mt.2009.167","volume":"17","author":"E Negroni","year":"2009","unstructured":"Negroni, E., Riederer, I., Chaouch, S., Belicchi, M., Razini, P., Di Santo, J., Torrente, Y., Butler-Browne, G. S., & Mouly, V. (2009). In vivo myogenic potential of human CD133+ muscle-derived stem cells: A quantitative study. Molecular Therapy: The Journal of the American Society of Gene Therapy, 17(10), 1771\u20131778. https:\/\/doi.org\/10.1038\/mt.2009.167","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"issue":"5","key":"10653_CR47","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/mt.2014.26","volume":"22","author":"J Meng","year":"2014","unstructured":"Meng, J., Chun, S., Asfahani, R., Lochm\u00fcller, H., Muntoni, F., & Morgan, J. (2014). Human skeletal muscle-derived CD133+ cells form functional satellite cells after intramuscular transplantation in immunodeficient host mice. Molecular Therapy, 22(5), 1008\u20131017. https:\/\/doi.org\/10.1038\/mt.2014.26","journal-title":"Molecular Therapy"},{"issue":"5","key":"10653_CR48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s004290050237","volume":"199","author":"RE Bittner","year":"1999","unstructured":"Bittner, R. E., Sch\u00f6fer, C., Weipoltshammer, K., Ivanova, S., Streubel, B., Hauser, E., Freilinger, M., H\u00f6ger, H., Elbe-B\u00fcrger, A., & Wachtler, F. (1999). Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anatomy and Embryology, 199(5), 391\u2013396. https:\/\/doi.org\/10.1007\/s004290050237","journal-title":"Anatomy and Embryology"},{"issue":"5","key":"10653_CR49","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/ncb1721","volume":"10","author":"JM Nygren","year":"2008","unstructured":"Nygren, J. M., Liuba, K., Breitbach, M., Stott, S., Thor\u00e9n, L., Roell, W., Geisen, C., Sasse, P., Kirik, D., Bj\u00f6rklund, A., Nerlov, C., Fleischmann, B. K., Jovinge, S., & Jacobsen, S. E. (2008). Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nature Cell Biology, 10(5), 584\u2013592. https:\/\/doi.org\/10.1038\/ncb1721","journal-title":"Nature Cell Biology"},{"issue":"Suppl 1","key":"10653_CR50","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.3727\/096368912X633798","volume":"21","author":"A Sharma","year":"2012","unstructured":"Sharma, A., Gokulchandran, N., Chopra, G., Kulkarni, P., Lohia, M., Badhe, P., & Jacob, V. C. (2012). Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life. Cell Transplantation, 21(Suppl 1), S79\u2013S90. https:\/\/doi.org\/10.3727\/096368912X633798","journal-title":"Cell Transplantation"},{"issue":"36","key":"10653_CR51","first-page":"2552","volume":"89","author":"XF Yang","year":"2009","unstructured":"Yang, X. F., Xu, Y. F., Zhang, Y. B., Wang, H. M., L\u00fc, N. W., Wu, Y. X., L\u00fc, X., Cui, J. P., Shan, H., Yan, Y., & Zhou, J. X. (2009). Functional improvement of patients with progressive muscular dystrophy by bone marrow and umbilical cord blood mesenchymal stem cell transplantations. Zhonghua Yi Xue Za Zhi, 89(36), 2552\u20132556.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"11","key":"10653_CR52","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1242\/dev.129.11.2773","volume":"129","author":"MG Minasi","year":"2002","unstructured":"Minasi, M. G., Riminucci, M., De Angelis, L., Borello, U., Berarducci, B., Innocenzi, A., Caprioli, A., Sirabella, D., Baiocchi, M., De Maria, R., Boratto, R., Jaffredo, T., Broccoli, V., Bianco, P., & Cossu, G. (2002). The meso-angioblast: A multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development (Cambridge, England), 129(11), 2773\u20132783. https:\/\/doi.org\/10.1242\/dev.129.11.2773","journal-title":"Development (Cambridge, England)"},{"key":"10653_CR53","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/B978-0-12-374729-7.00060-3","volume-title":"Essentials of Stem Cell Biology","author":"M Sampaolesi","year":"2009","unstructured":"Sampaolesi, M., & Cossu, G. (2009). Chapter 60 - Stem Cells for the Treatment of Muscular Dystrophy: Therapeutic Perspectives. In R. Lanza, J. Gearhart, B. Hogan, D. Melton, R. Pedersen, E. D. Thomas, J. Thomson, & I. Wilmut (Eds.), Essentials of Stem Cell Biology (2nd ed., pp. 543\u2013550). Academic Press.","edition":"2"},{"issue":"2","key":"10653_CR54","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/jcp.21200","volume":"213","author":"AI Caplan","year":"2007","unstructured":"Caplan, A. I. (2007). Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. Journal of Cellular Physiology, 213(2), 341\u2013347. https:\/\/doi.org\/10.1002\/jcp.21200","journal-title":"Journal of Cellular Physiology"},{"key":"10653_CR55","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.92824","author":"A Elhussieny","year":"2020","unstructured":"Elhussieny, A., Nogami, K., Sakai-Takemura, F., Maruyama, Y., Omar Abdelbakey, A., Abou El-kheir, W., Takeda, S., & Miyagoe-Suzuki, Y. (2020). Mesenchymal Stem Cells for Regenerative Medicine for Duchenne Muscular Dystrophy. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.92824","journal-title":"IntechOpen"},{"issue":"5","key":"10653_CR56","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","volume":"24","author":"S Kern","year":"2006","unstructured":"Kern, S., Eichler, H., Stoeve, J., Kl\u00fcter, H., & Bieback, K. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24(5), 1294\u20131301. https:\/\/doi.org\/10.1634\/stemcells.2005-0342","journal-title":"Stem Cells"},{"issue":"1","key":"10653_CR57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/21645515.2015.1030549","volume":"12","author":"Q Wang","year":"2016","unstructured":"Wang, Q., Yang, Q., Wang, Z., Tong, H., Ma, L., Zhang, Y., Shan, F., Meng, Y., & Yuan, Z. (2016). Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton\u2019s jelly as sources of cell immunomodulatory therapy. Human Vaccines & Immunotherapeutics, 12(1), 85\u201396. https:\/\/doi.org\/10.1080\/21645515.2015.1030549","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"9","key":"10653_CR58","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/mt.2016.125","volume":"24","author":"S Kwon","year":"2016","unstructured":"Kwon, S., Ki, S. M., Park, S. E., Kim, M. J., Hyung, B., Lee, N. K., Shim, S., Choi, B. O., Na, D. L., Lee, J. E., & Chang, J. W. (2016). Anti-apoptotic Effects of Human Wharton\u2019s Jelly-derived Mesenchymal Stem Cells on Skeletal Muscle Cells Mediated via Secretion of XCL1. Molecular Therapy: The Journal of the American Society of Gene Therapy, 24(9), 1550\u20131560. https:\/\/doi.org\/10.1038\/mt.2016.125","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"issue":"7","key":"10653_CR59","doi-asserted-by":"publisher","first-page":"e125754","DOI":"10.1172\/jci.insight.125754","volume":"4","author":"RG Rogers","year":"2019","unstructured":"Rogers, R. G., Fournier, M., Sanchez, L., Ibrahim, A. G., Aminzadeh, M. A., Lewis, M. I., & Marb\u00e1n, E. (2019). Disease-modifying bioactivity of intravenous cardiosphere-derived cells and exosomes in mdx mice. JCI Insight, 4(7), e125754. https:\/\/doi.org\/10.1172\/jci.insight.125754","journal-title":"JCI Insight"},{"key":"10653_CR60","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41551-018-0216-z","volume":"2","author":"E Marb\u00e1n","year":"2018","unstructured":"Marb\u00e1n, E. (2018). A mechanistic roadmap for the clinical application of cardiac cell therapies. Nature Biomedical Engineering, 2, 353\u2013361. https:\/\/doi.org\/10.1038\/s41551-018-0216-z","journal-title":"Nature Biomedical Engineering"},{"issue":"36","key":"10653_CR61","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1093\/eurheartj\/ehaa541","volume":"41","author":"RR Makkar","year":"2020","unstructured":"Makkar, R. R., Kereiakes, D. J., Aguirre, F., Kowalchuk, G., Chakravarty, T., Malliaras, K., Francis, G. S., Povsic, T. J., Schatz, R., Traverse, J. H., Pogoda, J. M., Smith, R. R., Marb\u00e1n, L., Ascheim, D. D., Ostovaneh, M. R., Lima, J. A. C., DeMaria, A., Marb\u00e1n, E., & Henry, T. D. (2020). Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): A randomized, placebo-controlled, double-blinded trial. European Heart Journal, 41(36), 3451\u20133458. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa541","journal-title":"European Heart Journal"},{"issue":"5","key":"10653_CR62","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1161\/CIRCRESAHA.109.210682","volume":"106","author":"I Chimenti","year":"2010","unstructured":"Chimenti, I., Smith, R. R., Li, T. S., Gerstenblith, G., Messina, E., Giacomello, A., & Marb\u00e1n, E. (2010). Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circulation Research, 106(5), 971\u2013980. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.210682","journal-title":"Circulation Research"},{"issue":"5","key":"10653_CR63","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","volume":"2","author":"AG Ibrahim","year":"2014","unstructured":"Ibrahim, A. G., Cheng, K., & Marb\u00e1n, E. (2014). Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports, 2(5), 606\u2013619. https:\/\/doi.org\/10.1016\/j.stemcr.2014.04.006","journal-title":"Stem Cell Reports"},{"issue":"3","key":"10653_CR64","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.stemcr.2018.01.023","volume":"10","author":"MA Aminzadeh","year":"2018","unstructured":"Aminzadeh, M. A., Rogers, R. G., Fournier, M., Tobin, R. E., Guan, X., Childers, M. K., Andres, A. M., Taylor, D. J., Ibrahim, A., Ding, X., Torrente, A., Goldhaber, J. M., Lewis, M., Gottlieb, R. A., Victor, R. A., & Marb\u00e1n, E. (2018). Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy. Stem Cell Reports, 10(3), 942\u2013955. https:\/\/doi.org\/10.1016\/j.stemcr.2018.01.023","journal-title":"Stem Cell Reports"},{"issue":"4","key":"10653_CR65","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/1756285615586123","volume":"8","author":"D Sienkiewicz","year":"2015","unstructured":"Sienkiewicz, D., Kulak, W., Okurowska-Zawada, B., & Paszko-Patej, G. (2015). Duchenne muscular dystrophy: Current cell therapies. Therapeutic Advances in Neurological Disorders, 8(4), 166\u2013177. https:\/\/doi.org\/10.1177\/1756285615586123","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"7","key":"10653_CR66","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/mt.2014.62","volume":"22","author":"M Noviello","year":"2014","unstructured":"Noviello, M., Tedesco, F. S., Bondanza, A., Tonlorenzi, R., Rosaria Carbone, M., Gerli, M. F. M., Marktel, S., Napolitano, S., Cicalese, M. P., Ciceri, F., Peretti, G., Cossu, G., & Bonini, C. (2014). Inflammation converts human mesoangioblasts into targets of alloreactive immune responses: Implications for allogeneic cell therapy of DMD. Molecular Therapy: The Journal of the American Society of Gene Therapy, 22(7), 1342\u20131352. https:\/\/doi.org\/10.1038\/mt.2014.62","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"issue":"5","key":"10653_CR67","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/01.tp.0000152799.16035.b7","volume":"79","author":"M Siemionow","year":"2005","unstructured":"Siemionow, M., Demir, Y., Mukherjee, A., & Klimczak, A. (2005). Development and maintenance of donor-specific chimerism in semi-allogenic and fully major histocompatibility complex mismatched facial allograft transplants. Transplantation, 79(5), 558\u2013567. https:\/\/doi.org\/10.1097\/01.tp.0000152799.16035.b7","journal-title":"Transplantation"},{"issue":"6","key":"10653_CR68","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/j.1600-6143.2008.02241.x","volume":"8","author":"M Siemionow","year":"2008","unstructured":"Siemionow, M., Klimczak, A., Unal, S., Agaoglu, G., & Carnevale, K. (2008). Hematopoietic stem cell engraftment and seeding permits multi-lymphoid chimerism in vascularized bone marrow transplants. American Journal of Transplantation, 8(6), 1163\u20131176. https:\/\/doi.org\/10.1111\/j.1600-6143.2008.02241.x","journal-title":"American Journal of Transplantation"},{"issue":"2","key":"10653_CR69","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12015-017-9792-7","volume":"14","author":"M Siemionow","year":"2018","unstructured":"Siemionow, M., Cwykiel, J., Heydemann, A., Garcia-Martinez, J., Siemionow, K., & Szilagyi, E. (2018). Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy. Stem Cell Reviews and Reports, 14(2), 189\u2013199. https:\/\/doi.org\/10.1007\/s12015-017-9792-7","journal-title":"Stem Cell Reviews and Reports"},{"issue":"10","key":"10653_CR70","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/sctm.21-0054","volume":"10","author":"M Siemionow","year":"2021","unstructured":"Siemionow, M., Langa, P., Harasymczuk, M., Cwykiel, J., Sielewicz, M., Smieszek, J., & Heydemann, A. (2021). Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle\u2019s function in Duchenne muscular dystrophy. Stem Cells Translational Medicine, 10(10), 1406\u20131418. https:\/\/doi.org\/10.1002\/sctm.21-0054","journal-title":"Stem Cells Translational Medicine"},{"issue":"4","key":"10653_CR71","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3233\/JND-150116","volume":"2","author":"A Hotta","year":"2015","unstructured":"Hotta, A. (2015). Genome Editing Gene Therapy for Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases, 2(4), 343\u2013355. https:\/\/doi.org\/10.3233\/JND-150116","journal-title":"Journal of Neuromuscular Diseases"},{"issue":"s2","key":"10653_CR72","doi-asserted-by":"publisher","first-page":"S303","DOI":"10.3233\/JND-210678","volume":"8","author":"N Elangkovan","year":"2021","unstructured":"Elangkovan, N., & Dickson, G. (2021). Gene Therapy for Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases, 8(s2), S303\u2013S316. https:\/\/doi.org\/10.3233\/JND-210678","journal-title":"Journal of Neuromuscular Diseases"},{"issue":"5","key":"10653_CR73","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/s1474-4422(03)00382-x","volume":"2","author":"R Kapsa","year":"2003","unstructured":"Kapsa, R., Kornberg, A. J., & Byrne, E. (2003). Novel therapies for Duchenne muscular dystrophy. The Lancet Neurology, 2(5), 299\u2013310. https:\/\/doi.org\/10.1016\/s1474-4422(03)00382-x","journal-title":"The Lancet Neurology"},{"issue":"2","key":"10653_CR74","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11940-008-0010-4","volume":"10","author":"E Ciafaloni","year":"2008","unstructured":"Ciafaloni, E., & Moxley, R. T. (2008). Treatment options for Duchenne muscular dystrophy. Current Treatment Options in Neurology, 10(2), 86\u201393. https:\/\/doi.org\/10.1007\/s11940-008-0010-4","journal-title":"Current Treatment Options in Neurology"},{"key":"10653_CR75","doi-asserted-by":"publisher","first-page":"107719","DOI":"10.1016\/j.pharmthera.2020.107719","volume":"220","author":"M Iftikhar","year":"2021","unstructured":"Iftikhar, M., Frey, J., Shohan, M. J., Malek, S., & Mousa, S. A. (2021). Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy. Pharmacology & Therapeutics, 220, 107719. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107719","journal-title":"Pharmacology & Therapeutics"},{"issue":"12","key":"10653_CR76","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/mus.880171210","volume":"17","author":"I Kinoshita","year":"1994","unstructured":"Kinoshita, I., Vilquin, J. T., Gu\u00e9rette, B., Asselin, I., Roy, R., & Tremblay, J. P. (1994). Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle & Nerve, 17(12), 1407\u20131415. https:\/\/doi.org\/10.1002\/mus.880171210","journal-title":"Muscle & Nerve"},{"issue":"6","key":"10653_CR77","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/00005072-199606000-00002","volume":"55","author":"I Kinoshita","year":"1996","unstructured":"Kinoshita, I., Roy, R., Dugr\u00e9, F. J., Gravel, C., Roy, B., Goulet, M., Asselin, I., & Tremblay, J. P. (1996). Myoblast transplantation in monkeys: Control of immune response by FK506. Journal of Neuropathology and Experimental Neurology, 55(6), 687\u2013697. https:\/\/doi.org\/10.1097\/00005072-199606000-00002","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"3","key":"10653_CR78","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ymthe.2003.11.023","volume":"9","author":"D Skuk","year":"2004","unstructured":"Skuk, D., Roy, B., Goulet, M., Chapdelaine, P., Bouchard, J. P., Roy, R., Dugr\u00e9, F. J., Lachance, J. G., Desch\u00eanes, L., H\u00e9l\u00e8ne, S., Sylvain, M., & Tremblay, J. P. (2004). Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Molecular Therapy\u202f: The Journal of the American Society of Gene Therapy, 9(3), 475\u2013482. https:\/\/doi.org\/10.1016\/j.ymthe.2003.11.023","journal-title":"Molecular Therapy : The Journal of the American Society of Gene Therapy"},{"issue":"4","key":"10653_CR79","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/01.jnen.0000218443.45782.81","volume":"65","author":"D Skuk","year":"2006","unstructured":"Skuk, D., Goulet, M., Roy, B., Chapdelaine, P., Bouchard, J. P., Roy, R., Dugr\u00e9, F. J., Sylvain, M., Lachance, J. G., Desch\u00eanes, L., Senay, H., & Tremblay, J. P. (2006). Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. Journal of Neuropathology and Experimental Neurology, 65(4), 371\u2013386. https:\/\/doi.org\/10.1097\/01.jnen.0000218443.45782.81","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"7","key":"10653_CR80","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/mt.2009.125","volume":"17","author":"JP Tremblay","year":"2009","unstructured":"Tremblay, J. P., Skuk, D., Palmieri, B., & Rothstein, D. M. (2009). A case for immunosuppression for myoblast transplantation in Duchenne muscular dystrophy. Molecular Therapy, 17(7), 1122\u20131124. https:\/\/doi.org\/10.1038\/mt.2009.125","journal-title":"Molecular Therapy"},{"issue":"4","key":"10653_CR81","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ymthe.2004.05.034","volume":"10","author":"SP Quenneville","year":"2004","unstructured":"Quenneville, S. P., Chapdelaine, P., Rousseau, J., Beaulieu, J., Caron, N. J., Skuk, D., Mills, P., Olivares, E. C., Calos, M. P., & Tremblay, J. P. (2004). Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: Stable expression of a full-length-dystrophin fusion gene by human myoblasts. Molecular Therapy\u202f: The Journal of the American Society of Gene Therapy, 10(4), 679\u2013687. https:\/\/doi.org\/10.1016\/j.ymthe.2004.05.034","journal-title":"Molecular Therapy : The Journal of the American Society of Gene Therapy"},{"issue":"14","key":"10653_CR82","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/sj.gt.3302505","volume":"12","author":"S Li","year":"2005","unstructured":"Li, S., Kimura, E., Fall, B. M., Reyes, M., Angello, J. C., Welikson, R., Hauschka, S. D., & Chamberlain, J. S. (2005). Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin. Gene Therapy, 12(14), 1099\u20131108. https:\/\/doi.org\/10.1038\/sj.gt.3302505","journal-title":"Gene Therapy"},{"issue":"2","key":"10653_CR83","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/sj.mt.6300047","volume":"15","author":"SP Quenneville","year":"2007","unstructured":"Quenneville, S. P., Chapdelaine, P., Skuk, D., Paradis, M., Goulet, M., Rousseau, J., Xiao, X., Garcia, L., & Tremblay, J. P. (2007). Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: Human cells and primate models. Molecular Therapy: The Journal of the American Society of Gene Therapy, 15(2), 431\u2013438. https:\/\/doi.org\/10.1038\/sj.mt.6300047","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10653_CR84","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.scr.2018.05.004","volume":"30","author":"J Meng","year":"2018","unstructured":"Meng, J., Muntoni, F., & Morgan, J. (2018). CD133+ cells derived from skeletal muscles of Duchenne muscular dystrophy patients have a compromised myogenic and muscle regenerative capability. Stem Cell Research, 30, 43\u201352. https:\/\/doi.org\/10.1016\/j.scr.2018.05.004","journal-title":"Stem Cell Research"},{"issue":"6","key":"10653_CR85","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/jnr.10337","volume":"69","author":"JR Sanchez-Ramos","year":"2002","unstructured":"Sanchez-Ramos, J. R. (2002). Neural cells derived from adult bone marrow and umbilical cord blood. Journal of Neuroscience Research, 69(6), 880\u2013893. https:\/\/doi.org\/10.1002\/jnr.10337","journal-title":"Journal of Neuroscience Research"},{"issue":"4","key":"10653_CR86","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/s0092-8674(02)01078-4","volume":"111","author":"MA LaBarge","year":"2002","unstructured":"LaBarge, M. A., & Blau, H. M. (2002). Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell, 111(4), 589\u2013601. https:\/\/doi.org\/10.1016\/s0092-8674(02)01078-4","journal-title":"Cell"},{"issue":"2","key":"10653_CR87","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.bbadis.2006.08.011","volume":"1772","author":"FD Price","year":"2007","unstructured":"Price, F. D., Kuroda, K., & Rudnicki, M. A. (2007). Stem cell based therapies to treat muscular dystrophy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1772(2), 272\u2013283. https:\/\/doi.org\/10.1016\/j.bbadis.2006.08.011","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"5","key":"10653_CR88","doi-asserted-by":"publisher","first-page":"403","DOI":"10.5966\/sctm.2011-0064","volume":"1","author":"N Cuende","year":"2012","unstructured":"Cuende, N., Rico, L., & Herrera, C. (2012). Concise review: Bone marrow mononuclear cells for the treatment of ischemic syndromes: Medicinal product or cell transplantation? Stem Cells Translational Medicine, 1(5), 403\u2013408. https:\/\/doi.org\/10.5966\/sctm.2011-0064","journal-title":"Stem Cells Translational Medicine"},{"issue":"1","key":"10653_CR89","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.4081\/ejtm.2016.5522","volume":"26","author":"A Sharma","year":"2016","unstructured":"Sharma, A., Sane, H., Gokulchandra, N., Sharan, R., Paranjape, A., Kulkarni, P., Yadav, J., & Badhe, P. (2016). Effect of Cellular Therapy in Progression of Becker\u2019s Muscular Dystrophy: A Case Study. European Journal of Translational Myology, 26(1), 5522. https:\/\/doi.org\/10.4081\/ejtm.2016.5522","journal-title":"European Journal of Translational Myology"},{"key":"10653_CR90","doi-asserted-by":"publisher","first-page":"207326","DOI":"10.1155\/2011\/207326","volume":"2011","author":"TJ Burdon","year":"2011","unstructured":"Burdon, T. J., Paul, A., Noiseux, N., Prakash, S., & Shum-Tim, D. (2011). Bone marrow stem cell derived paracrine factors for regenerative medicine: Current perspectives and therapeutic potential. Bone Marrow Research, 2011, 207326. https:\/\/doi.org\/10.1155\/2011\/207326","journal-title":"Bone Marrow Research"},{"key":"10653_CR91","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-1-61779-343-1_4","volume":"798","author":"M Quattrocelli","year":"2012","unstructured":"Quattrocelli, M., Palazzolo, G., Perini, I., Crippa, S., Cassano, M., & Sampaolesi, M. (2012). Mouse and human mesoangioblasts: Isolation and characterization from adult skeletal muscles. Methods in Molecular Biology, 798, 65\u201376. https:\/\/doi.org\/10.1007\/978-1-61779-343-1_4","journal-title":"Methods in Molecular Biology"},{"key":"10653_CR92","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1038\/ncomms7364","volume":"6","author":"C Bonfanti","year":"2015","unstructured":"Bonfanti, C., Rossi, G., Tedesco, F. S., Giannotta, M., Benedetti, S., Tonlorenzi, R., Antonini, S., Marazzi, G., Dejana, E., Sassoon, D., Cossu, G., & Messina, G. (2015). PW1\/Peg3 expression regulates key properties that determine mesoangioblast stem cell competence. Nature Communications, 6, 6364. https:\/\/doi.org\/10.1038\/ncomms7364","journal-title":"Nature Communications"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-023-10653-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-023-10653-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-023-10653-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T09:32:44Z","timestamp":1705743164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-023-10653-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10653"],"URL":"https:\/\/doi.org\/10.1007\/s12015-023-10653-8","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"assertion":[{"value":"3 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Both authors hereby provide our consent to participate in the submission of the manuscript titled \"Cell Therapy Strategies for Duchenne Muscular Dystrophy: A Systematic Review of Clinical Applications\" to the Stem Cell Review and Reports Journal. We understand and agree to the following terms and conditions:We confirm that we have read, reviewed, and contributed to the creation of the manuscript titled \"Cell Therapy Strategies for Duchenne Muscular Dystrophy: A Systematic Review of Clinical Applications\". We are aware of its content and have made substantial intellectual contributions to its development. We understand that the submission of this manuscript is being made to the Stem Cell Review and Reports Journal and that it is subject to the journal's peer-review process and editorial policies. We acknowledge that we have reviewed and complied with the journal's author guidelines and ethical standards for manuscript submission, including the guidelines on authorship, originality, and conflicts of interest. We understand that the manuscript may be reviewed by independent experts and that revisions may be required before publication. We agree that the corresponding author, Ayberk Akat Ph.D., is authorized to act on our behalf regarding all matters related to the submission, review, and publication of this manuscript, including correspondence with the journal's editorial team. We affirm that the content of this manuscript is original, has not been previously published elsewhere, and is not under consideration for publication in any other journal. We understand that if the manuscript is accepted for publication, it will be made available to the public through the Stem Cell Review and Reports Journal and other platforms. We grant the Stem Cell Review and Reports Journal the right to use and distribute the manuscript in accordance with its publication policies, including online and in print. We confirm that all co-authors have been informed of and consent to the submission of this manuscript to the Stem Cell Review and Reports Journal. We acknowledge that any changes to authorship, conflicts of interest, or other relevant information will be promptly communicated to the journal's editorial team. We hereby provide our consent to participate in the submission of this manuscript and confirm that we have reviewed and agree to the terms outlined above.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors reviewed the results and approved the final version of the manuscript to be published. All authors hereby give consent for the publication of our personal information in the Stem Cell Review and Reports Journal. This information includes, but is not limited to, our name, age, sex, and any other information that is included in the article. We also understand that we are granting the publisher the exclusive right to publish the article in all languages, in whole or in part. We retain the right to use the article for our own purposes, such as teaching, lecturing, and presenting at conferences.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}